{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:15Z","timestamp":1787027295465,"version":"build-2736575974"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Nitrous oxide (N\n                      <jats:sub>2<\/jats:sub>\n                      O) is used for anesthetic purposes but has gained popularity as a recreational substance. Despite its potentially severe adverse effects, knowledge about N\n                      <jats:sub>2<\/jats:sub>\n                      O use within psychiatric populations is limited. This study aimed to evaluate the life-time prevalence and patterns of N\n                      <jats:sub>2<\/jats:sub>\n                      O consumption among patients with psychiatric disorders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective observational cohort study was conducted at the Department of Psychiatry, Psychotherapy and Psychosomatics of the Rheinisch-Westf\u00e4lische Technische Hochschule (RWTH) Aachen University Hospital, involving assessments of N\n                      <jats:sub>2<\/jats:sub>\n                      O use lifetime prevalence among patients in various psychiatric settings over a six-month period in 2024. Further data on demographic characteristics and psychiatric diagnoses were collected from electronic patient records.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 287 screened records, 22 patients (7.67%) reported a N\n                      <jats:sub>2<\/jats:sub>\n                      O use history, with a positive statistical relationship between younger age and positive lifetime prevalence (mean age: 28.14 \u00b1 7.29 years, range 19\u201348 years, 6\/22 female). Most users acquired N\n                      <jats:sub>2<\/jats:sub>\n                      O through low-threshold means such as friends or social events. The predominant psychiatric diagnoses among users included major depressive disorder, cannabis-related disorder and attention deficit and hyperactivity disorder.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This study highlights the concerning life-time prevalence of N\n                      <jats:sub>2<\/jats:sub>\n                      O use in a clinical psychiatric sample, emphasizing the need for increased awareness and education regarding its potential risks and side effects. Given the vulnerability of this population to substance-related issues, routine assessment for N\n                      <jats:sub>2<\/jats:sub>\n                      O use should be integrated into standard psychiatric evaluations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1670500","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:01:25Z","timestamp":1759327285000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Nitrous oxide use and psychiatric disorders: a retrospective clinical cohort study on prevalence and patterns"],"prefix":"10.3389","volume":"16","author":[{"given":"Rebecca","family":"Paetow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike Franziska","family":"Dohrn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Finner-Pr\u00e9vel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona","family":"Boesehans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariush","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Frodl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/jcm8040551","article-title":"Global burden related to nitrous oxide exposure in medical and recreational settings: A systematic review and individual patient data meta-analysis","volume":"8","author":"Oussalah","year":"2019","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev297","article-title":"The increasing recreational use of nitrous oxide: history revisited","volume":"116","author":"Randhawa","year":"2016","journal-title":"Br J Anaesth"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biopsych.2015.04.007","article-title":"Potential pathways involved in the rapid antidepressant effects of nitrous oxide","volume":"78","author":"Zarate","year":"2015","journal-title":"Biol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e3182a771ea","article-title":"Horace wells\u2019 Demonstration of nitrous oxide in boston","volume":"119","author":"Haridas","year":"2013","journal-title":"Anesthesiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1874473711666181008163107","article-title":"Mini-review: A brief history of nitrous oxide (N2O) use in neuropsychiatry","volume":"11","author":"Gillman","year":"2019","journal-title":"Curr Drug Res Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/0269881116632375","article-title":"Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use","volume":"30","author":"Kaar","year":"2016","journal-title":"J Psychopharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8040073","article-title":"Abuse of prescription drugs in the context of novel psychoactive substances (NPS): A systematic review","volume":"8","author":"Schifano","year":"2018","journal-title":"Brain Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2012.09.147","article-title":"Current \u201clegal highs","volume":"44","author":"Johnson","year":"2013","journal-title":"J Emergency Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"103519","DOI":"10.1016\/j.drugpo.2021.103519","article-title":"Alarming increase in poisonings from recreational nitrous oxide use after a change in EU-legislation, inquiries to the Dutch Poisons Information Center","volume":"100","author":"van Riel","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-024-01427-z","article-title":"Nitrous oxide as a party drug","volume":"73","author":"Ziegenfu\u00df","year":"2024","journal-title":"Anaesthesiologie"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12372","article-title":"Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature","volume":"25","author":"Garakani","year":"2016","journal-title":"Am J Addict"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.10.017","article-title":"Recreational nitrous oxide use: Prevalence and risks","volume":"73","author":"van Amsterdam","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000530123","article-title":"High incidence of signs of neuropathy and self-reported substance use disorder for nitrous oxide in patients intoxicated with nitrous oxide","volume":"29","author":"Nugteren - Van Lonkhuyzen","year":"2023","journal-title":"Eur Addict Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4318015","article-title":"Pneumomediastinum secondary to barotrauma after recreational nitrous oxide inhalation","volume":"2016","author":"Jeddy","year":"2016","journal-title":"Case Rep Gastroint Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2020.1782160","article-title":"Frostbite injury: an unknown risk when using nitrous oxide as a party drug","volume":"122","author":"Quax","year":"2022","journal-title":"Acta Chirurgica Belgica"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001151","article-title":"Psychiatric and other medical manifestations of nitrous oxide abuse","volume":"40","author":"Chien","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314747","article-title":"Mechanisms involved in the neurotoxicity and abuse liability of nitrous oxide: A narrative review","volume":"23","author":"Brunt","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2010.10.033","article-title":"Nitrous oxide-induced B12 deficiency myelopathy: Perspectives on the clinical biochemistry of vitamin B12","volume":"301","author":"Hathout","year":"2011","journal-title":"J Neurol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"112894","DOI":"10.1016\/j.fct.2022.112894","article-title":"Nitrous oxide abuse in the emergency practice, and Review of toxicity mechanisms and potential markers","volume":"162","author":"Joncquel Chevalier-Curt","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1742-6723.13997","article-title":"Review article: Clinical manifestations and outcomes of chronic nitrous oxide misuse: A systematic review","volume":"34","author":"Marsden","year":"2022","journal-title":"Emergency Med Australasia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02673-x","article-title":"Thromboembolic complications of recreational nitrous oxide (ab)use: a systematic review","volume":"54","author":"Oulkadi","year":"2022","journal-title":"J Thromb Thromb"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119882532","article-title":"Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational users","volume":"34","author":"Winstock","year":"2020","journal-title":"J Psychopharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2533","DOI":"10.1002\/brb3.2533","article-title":"Analysis of clinical characteristics and prognostic factors in 110 patients with nitrous oxide abuse","volume":"12","author":"Yu","year":"2022","journal-title":"Brain Behav"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/BF03161175","article-title":"Nitrous oxide \u201cwhippit\u201d abuse presenting with cobalamin responsive psychosis","volume":"2","author":"Sethi","year":"2006","journal-title":"J Med Toxicol: Off J Am Coll Med Toxicol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2344\/0003-3006(2007)54[9:AIUTAO]2.0.CO;2","article-title":"Advances in understanding the actions of nitrous oxide","volume":"54","author":"Emmanouil","year":"2007","journal-title":"Anesth Prog"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nm0498-460","article-title":"Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin","volume":"4","author":"Jevtovi\u0107-Todorovi\u0107","year":"1998","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5535\/arm.2019.43.4.530","article-title":"Subacute combined degeneration caused by nitrous oxide intoxication: A report of two cases","volume":"43","author":"Choi","year":"2019","journal-title":"Ann Rehabil Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10140-013-1152-6","article-title":"Nitrous oxide induced myeloneuropathy: A case report","volume":"21","author":"Rheinboldt","year":"2014","journal-title":"Emergency Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14779","article-title":"Nitrous oxide-induced neurotoxicity: A case report and literature review","volume":"87","author":"Thayabaran","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/0954026021000045930","article-title":"Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey","volume":"15","author":"Farrell","year":"2003","journal-title":"Int Rev Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-024-00361-0","article-title":"Increase of nitrous oxide-induced neurological disorders \u2013 a German multicenter experience","volume":"7","author":"Mei\u00dfner","year":"2025","journal-title":"Neurol Res Pract"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s42466-025-00385-0","article-title":"Neurological disorders caused by recreational use of nitrous oxide\u2014a retrospective study from a German metropolitan area and review of the literature","volume":"7","author":"Tshagharyan","year":"2025","journal-title":"Neurol Res Pract"},{"key":"B34","unstructured":"International statistical classification of diseases and related health problems (10th ed.)\n          \n          2016"},{"key":"B35","volume-title":"Microsoft Excel","year":"2018"},{"key":"B36","volume-title":"R: A language and environment for statistical Computing","year":"2023"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/02698811221082442","article-title":"Increasing recreational nitrous oxide use: Should we worry? A narrative review","volume":"36","author":"van Amsterdam","year":"2022","journal-title":"J Psychopharmacol"},{"key":"B38","unstructured":"Monitoring-System Drogentrends, Jahresbericht 2019, Drogentrends in Frankfurt am Main\n          \n          \n            \n              Werse\n              B\n            \n            \n              Kamphausen\n              G\n            \n            \n              Martens\n              J\n            \n          \n          \n          2020"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15391","article-title":"Just \u2018nanging\u2019 around \u2013 harmful nitrous oxide use: a retrospective case series and review of Internet searches, social media posts and the coroner\u2019s database","volume":"52","author":"Chiew","year":"2022","journal-title":"Internal Med J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103861","article-title":"Becoming a nitrous oxide user on social media: Learning to maximise pleasures and minimise harms","volume":"109","author":"MacLean","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191811567","article-title":"A systematic review of recreational nitrous oxide use: implications for policy, service delivery and individuals","volume":"19","author":"Allan","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B42","volume-title":"Nitrous Oxide Ban: Guidance","year":"2023"},{"key":"B43","volume-title":"Recreational use of nitrous oxide: a growing concern for Europe","author":"Van Aerts","year":"2022"},{"key":"B44","unstructured":"Dutch to ban laughing gas over fears for health and road safety. The Guardian\n          \n          \n            \n              Ranking\n              J\n            \n          \n          \n          2022"},{"key":"B45","volume-title":"Resolution protocol of the 128th German Medical Conference","year":"2024"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(24)00298-6","article-title":"Tackling the growing burden of nitrous oxide-induced public health harms","volume":"10","author":"Zaloum","year":"2025","journal-title":"Lancet Public Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2025.100190","article-title":"Addressing the unregulated use of nitrous oxide canisters","volume":"6","author":"Yockey","year":"2025","journal-title":"J Med Surg Public Health"},{"key":"B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp053113","article-title":"Mood disorders and substance use disorder: a complex comorbidity","volume":"3","author":"Quello","year":"2005","journal-title":"Sci Pract Perspect"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/00048674211054740","article-title":"Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis","volume":"56","author":"Saha","year":"2022","journal-title":"Aust New Z J Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am J Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2020.00037","article-title":"The nucleus accumbens: A common target in the comorbidity of depression and addiction","volume":"14","author":"Xu","year":"2020","journal-title":"Front Neural Circuits"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.06.004","article-title":"DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample","volume":"27","author":"Hayley","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"B53","first-page":"4","article-title":"The nature of the relationship between attention-deficit\/hyperactivity disorder and substance use","author":"Wilens","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0992","article-title":"Attention-deficit\/hyperactivity disorder and substance abuse","volume":"134","author":"Harstad","year":"2014","journal-title":"Pediatrics"},{"key":"B55","doi-asserted-by":"publisher","first-page":"104575","DOI":"10.1016\/j.neubiorev.2022.104575","article-title":"Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence","volume":"135","author":"Ivanov","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15030292","article-title":"The use of novel stimulants in ADHD self-medication: A mixed methods analysis","volume":"15","author":"Holborn","year":"2025","journal-title":"Brain Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1990.tb03084.x","article-title":"Involvement of tobacco in alcoholism and illicit drug use","volume":"85","author":"Henningfield","year":"1990","journal-title":"Br J Addict"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2016.11.017","article-title":"Polydrug use among urban adolescent cigarette smokers","volume":"66","author":"McKelvey","year":"2017","journal-title":"Addictive Behav"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1081\/JA-200066736","article-title":"Party drugs: properties, prevalence, patterns, and problems","volume":"40","author":"Maxwell","year":"2005","journal-title":"Subst Use Misuse"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7412a3","article-title":"Notes from the field: recreational nitrous oxide misuse \u2014 Michigan 2019\u20132023","volume":"74","author":"Vohra","year":"2025","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.11.016","article-title":"Nitrous oxide for treatment-resistant major depression: A proof-of-concept trial","volume":"78","author":"Nagele","year":"2015","journal-title":"Biol Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1670500\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:01:27Z","timestamp":1759327287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1670500\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":61,"alternative-id":["10.3389\/fpsyt.2025.1670500"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1670500","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"1670500"}}